{
  "term": "Sulfasalazine",
  "role": "concept",
  "parent_concepts": [
    "Medicine"
  ],
  "layer": 5,
  "domain": "PhysicalWorld",
  "definition": "Sulfasalazine (SSZ),\nsold under the trade name Azulfidine among others, is a medication\nused to treat rheumatoid arthritis, ulcerative colitis, and Crohn's\ndisease. It is considered by some to be a first-line treatment in\nrheumatoid arthritis. It is taken by mouth. Significant side\neffects occur in about 25% of people. Commonly these include loss\nof appetite, nausea, headache, and rash. Severe side effects\ninclude bone marrow suppression, liver problems, Stevens\u2013Johnson\nsyndrome, and kidney problems. It should not be used in\npeople allergic to aspirin or sulfonamide. Use during pregnancy\nappears to be safe for the baby. Sulfasalazine is in the\ndisease-modifying antirheumatic drugs (DMARDs) family of\nmedications. It is unclear exactly how it works.[from Wikipedia]",
  "definition_source": "SUMO",
  "aliases": [
    "sulfasalazine"
  ],
  "wordnet": {
    "synsets": [
      "sulfasalazine.n.01"
    ],
    "canonical_synset": "sulfasalazine.n.01",
    "lemmas": [
      "sulfasalazine"
    ],
    "pos": "noun"
  },
  "relationships": {
    "related": [],
    "antonyms": [],
    "has_part": [
      "Azulfidine"
    ],
    "part_of": []
  },
  "safety_tags": {
    "risk_level": "low",
    "impacts": [],
    "treaty_relevant": false,
    "harness_relevant": false
  },
  "training_hints": {
    "positive_examples": [],
    "negative_examples": [],
    "disambiguation": "",
    "seed_terms": [
      "sulfasalazine"
    ]
  },
  "children": [
    "Azulfidine"
  ],
  "is_category_lens": true,
  "child_count": 1
}